ロード中...
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
BACKGROUND: The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V(2)-receptor antagonists inhibit cyst growth and slow the decline of kidney function. METHODS: In this phase...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3760207/ https://ncbi.nlm.nih.gov/pubmed/23121377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1205511 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|